Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Tianjin Institute of Medical Pharmaceutical Development Center is the commercial and industrialization arm of the Tianjin Institute of Medical Pharmaceutical (TIMP), a prominent research institution in Tianjin, China. The center specializes in the research, development, and technical transfer of pharmaceutical products, with a focus on small molecule drugs and the modernization of traditional Chinese medicine (TCM). It provides comprehensive R&D services, including chemical synthesis, formulation development, and quality control, to support the pharmaceutical industry's needs. The center is particularly noted for its work in cardiovascular and metabolic therapeutic areas, often collaborating with the Tianjin Pharmaceutical Group to bring products like sustained-release formulations to the market. As a state-owned entity, it plays a vital role in bridging the gap between academic research and industrial production within the regional healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Development Center, Tianjin Institute of Medical.